Cases & Deals

Share

Baxter Ventures invests in TVA Medical

September 2015

Client(s) Baxter International Inc.

Jones Day represented Baxter Ventures in connection with its purchase of Series C Preferred Stock in a private placement by TVA Medical, Inc., a developer of minimally invasive therapies for end-stage renal disease. The round was led by newly vested Baxter Ventures and joined by new investor Boston Scientific and returning investors Sante Ventures, S3 Ventures, and TriStar Technology Ventures.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.